Overview

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.
Phase:
Phase 3
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Aztreonam
Fluoroquinolones
Vancomycin